There is an urgent need for effective treatment modalities for coronavirus disease 2019
(COVID-19). Data for the use of steroids in COVID-19 is emerging. We conducted this …

Mycobacterium indicus pranii (MIP), previously called Mw vaccine, is a one-of-a-kind
immunomodulatory vaccine. It was indigenously developed in India for use in leprosy. MIP is …

Background: Many recent studies have investigated the role of drug interventions for
coronavirus disease 2019 (COVID-19) infection. However, an important question has been …

Background: To date, there has been little agreement on what drug is the" best" drug for
treating severe COVID-19 patients. This study aimed to assess the efficacy and safety of …

The kinetics of NKG2C+ adaptive natural killer (ANK) cells and NKG2A+ inhibitory NK (iNK)
cells with respect to the incidence of SARS-CoV-2 infection were studied for 6 months in a …

Abstract The Special Interest Group (SIG) on leprosy thought it to be prudent to revisit its
previous practice recommendations through this update. During this period, the pandemic …

Previous studies have shown that the in vivo administration of soil-derived bacteria with anti-
inflammatory and immunoregulatory properties, such as Mycobacterium vaccae NCTC …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces the production of
proinflammatory cytokines, which results in a cytokine storm, and immune‐modulators like …

Dear Editor, In an attempt to mitigate the severity of the disease, several medications have
been used in patients with COVID-19 (coronavirus disease 2019). 1 One such therapy is …

The effective treatment modalities for severe coronavirus disease 2019 (COVID-19) are
needed. As the primary cause of mortality is a hyperinflammatory state, the interleukin-6 …